June 3, 2019
CMIC Healthcare Co., Ltd.

CMIC Healthcare Co., Ltd. (Head Office: Minato-ku, Tokyo, President & CEO: Shinnichi Keino, hereinafter “CMIC Healthcare”) today announced that on June 1, it had completed succeeding the “harmo” , the electronic prescription record service, of Sony Corporation (Head Office: Minato-ku, Tokyo, President and CEO, Kenichiro Yoshida, hereinafter “Sony”), based on the transfer agreement concluded with Sony first announced on March 25, 2019, and started operations.

【CMIC Healthcare Co., Ltd.】

As a wholly owned subsidiary of CMIC Holdings, CMIC Healthcare provides services and solutions to patients. The main business of CMIC Healthcare is running a medical call center operated by nurses, pharmacists, clinical laboratory technicians, and dietitians, as well as maintaining a portal site called “HelC+”,and a patient support program that supports the adherence to medications and continuous visits.
For more information on CMIC Healthcare services, visit the website: https://www.cmic-healthcare.co.jp/


CMIC Group started business in 1992 as the first CRO in Japan, and the company today provides comprehensive support services for the development, manufacturing, sales, and marketing of pharmaceutical products. Also, the company operates to respond to diversifying needs by managing the Healthcare Business sector and developing and selling diagnostic pharmaceuticals and orphan drugs. CMIC Group has developed a unique business model called Pharmaceutical Value Creator (PVC) based on its abundant accumulated experience and knowledge as a CRO pioneer. CMIC utilizes the PVC to create new value in the healthcare field.
For more information, visit CMIC Group’s website: https://www.cmicgroup.com/e/